SDIC Leads $39M Round In Chinese Small Interfering RNA Drug Developer Ribo
March 17, 2017 — 19:14 CST
This Data Is Locked!
This area is available only to Subscribers.
An advanced manufacture industrial investment fund under China’s SDIC Fund Management Co. has led a RMB270 million (US$39 million) series B round in Suzhou Ribo... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals